MDL Sought for Apple Lawsuits Over AirTag Stalking Problems and Damages Caused By Unauthorized Tracking
Scope Infection Lawsuit Patients across the United States have filed medical scope infection lawsuits after contaminated endoscopes and duodenoscopes allegedly transmitted dangerous bacterial infections during procedures such as ERCP, colonoscopy, and other endoscopic treatments.
Spinal Cord Stimulator Lawsuit Spinal cord stimulator lawsuits allege that implanted pain devices malfunctioned, migrated, or caused nerve damage, often forcing patients to undergo revision or removal surgery.
Chlorpyrifos Parkinsonโs Disease Lawsuit Chlorpyrifos lawsuits are being investigated for individuals diagnosed with Parkinsonโs disease after direct, residential, occupational or Gulf War pesticide exposure.
Ozempic Lawsuit Lawyers are pursuing Ozempic lawsuits, Wegovy lawsuits and Mounjaro lawsuits over gastroparesis or stomach paralysis, which can leave users with long-term gastrointestinal side effects
Suboxone Tooth Decay Lawsuit Lawsuits are being pursued by users of Suboxone who experienced tooth loss, broken teeth or required dental extractions. Settlement benefits may be available.
Depo-Provera Lawsuit Depo-Provera lawsuits are being investigated for women who developed meningioma brain tumors after receiving Depo-Provera birth control shots, claiming that Pfizer failed to adequately disclose side effects.
Hair Relaxer Lawsuit Regular exposure to chemicals in hair relaxer may cause uterine cancer, ovarian cancer and other injuries. Women diagnosed with cancer may be eligible for settlement benefits.
Nitrous Oxide Lawsuit Individuals who suffered harm, or families who lost a loved one after using nitrous oxide products may be eligible for financial compensation through a nitrous oxide lawsuit.
Breast Mesh Lawsuit Lawyers are investigating breast mesh lawsuits for women who suffered infections, pain, or implant failure from internal bra implants used in breast reconstruction surgery.
Bard PowerPort Lawsuit Serious and life-threatening injuries have been linked to problems with Bard PowerPort. Lawsuits are now being pursued by individuals who suffered injuries from the implantable port catheter fracturing or migrating.
Environmentalists Say EPA Defying Court Ruling That Bans Dicamba June 11, 2020 Irvin Jackson Add Your CommentsConfusion has erupted in the wake of a recent court ruling, which stripped away federal approval for the weed killer dicamba, with environmental groups accusing federal regulators of failing to heed the court order, and states complaining that not every jurisdiction is handling the situation the same.Last week, the U.S. Ninth Circuit Court of Appeals vacated the U.S. Environmental Protection Agency (EPA) approval of dicamba formulations for the weed killers XtendiMax, FeXapan and Engenia. The court ruled that the EPA did not pay enough attention to the risk of crop damage from dicamba, and that it even downplayed some of those risks.As a result, the EPA issued a final cancellation order (PDF), which allows limited distribution of existing stocks of the three weed killers by commercial applicators until July 31.Do You Know about…Spinal Cord Stimulator lawsuitsSpinal cord stimulator lawsuits are being investigated for individuals who suffered unnecessary shocks, burns or other problems, often resulting in the need for additional surgery to remove the SCS.Learn MoreSEE IF YOU QUALIFY FOR COMPENSATIONDo You Know AboutโฆSpinal Cord Stimulator lawsuitsSpinal cord stimulator lawsuits are being investigated for individuals who suffered unnecessary shocks, burns or other problems, often resulting in the need for additional surgery to remove the SCS.Learn MoreSEE IF YOU QUALIFY FOR COMPENSATIONHowever, critics say the court ruling gives no such leeway, and that with the vacating of the herbicidesโ licenses, its use should end immediately. Whatโs more, some states complain the EPA final cancellation order is not being interpreted the same in every state.Dicamba is a synthetic herbicide that is sold under the brand names Xtendimax, Engenia, and Fexapan, all of which involve so-called “over-the-top” applications, where it is applied on crops emerging from the ground.Although dicamba has been used for years by farmers nationwide to control weeds, traditionally it was only applied during certain times of the year. However, use of the herbicide increased dramatically after new seeds were introduced in 2016, which were genetically modified to be tolerant of the weedkiller, allowing farmers to use dicamba “over-the-top” after purchasing the special seeds. However, as the weedkiller has drifted onto neighboring farms, it has caused wide-spread damage to crops of farmers who decided not to purchase the genetically modified seeds.On June 8, the Center for Food Safety lambasted the EPA cancellation order, calling it disingenuous and noting that the court called for the immediate vacating of dicamba approval, not a delayed one.โTodayโs disingenuous order from EPA flies in the face of the Court decision holding dicamba-based pesticides unlawful. It ignores the well-documented and overwhelming evidence of substantial drift harm to farmers from another disastrous spraying season,โ the Centerโs legal counsel said in a press release. โIt raises the same arguments in favor of continued use that the Court has already rejected.โThe Center says it will go to the court to ensure that the ruling is enforced. However, the EPA states limited use of dicamba is warranted by portions of its 1991 Existing Stocks Policy.โThe Court vacated those registrations on the view that EPA substantially understated risks that it acknowledged and failed to acknowledge other risks,โ the EPA cancellation order states. โIn light of the Court’s reasoning for its vacatur, EPA is substantially restricting sale and distribution of existing stocks of these dicamba products.โEnvironmental groups are not the only ones complaining about the order, however, as some state officials say the order and ruling have sewn confusion among the agricultural industry.An official with the Wisconsin Agribusiness Association told Brownfieldagnews.com on June 10 that Wisconsin believes the ruling says you can use dicamba if you have it, but you canโt sell it, and any unsold products must be sent back to the distributor. However, in Illinois they are interpreting the order as saying anything in warehouses as of June 3 can be sold until July 31.The EPA approved this latest version of dicamba in November 2016; a decision that is also nowย under investigation by the Office of Inspector General (OIG). The agency renewed the approvals in late 2018.Dicamba Crop Damage LawsuitsDozens of dicamba drift lawsuitsย have been filed since August 2017, alleging Monsanto rushed the system to market and either withheld or concealed information from regulatory authorities about the volatility of dicamba-resistant crops.Farmers and environmental groups say the herbicide drifts onto neighboring crops that are not dicamba tolerant, killing them and forcing farmers to buy the genetically engineered seeds so their crops arenโt killed by dicamba.In February, a Missouri jury awardedย $265 millionย to a peach farmer in the first dicamba crop damage lawsuit to go to trial. The verdict included $15 million in compensatory damages and $250 million in punitive damages, designed to punish Monsanto and BASF for their reckless behavior in marketing the widespread use of the weed killer.The dicamba lawsuits claimed the high volatility is seen as a feature by the manufacturers, meant to force other farmers to use their expensive products to grow dicamba-tolerant GMO crops if they donโt want to suffer losses when their neighbors spray. Written by: Irvin JacksonSenior Legal Journalist & Contributing EditorIrvin Jackson is a senior investigative reporter at AboutLawsuits.com with more than 30 years of experience covering mass tort litigation, environmental policy, and consumer safety. He previously served as Associate Editor at Inside the EPA and contributes original reporting on product liability lawsuits, regulatory failures, and nationwide litigation trends. Tags: BASF, Bayer, Dicamba, Engenia, Fexapan, Genetically Modified Organisms, Herbicide, Monsanto, XtendiMaxMore Lawsuit Stories Nearly 4,000 Bard PowerPort Lawsuits Are Awaiting Outcome of Upcoming Bellwether Trials August 12, 2026 MDL Sought for Apple Lawsuits Over AirTag Stalking Problems and Damages Caused By Unauthorized Tracking August 12, 2026 Recalled LINX Device Caused Recurrence of GERD Symptoms, Requiring Surgical Removal: Lawsuit August 12, 2026 0 Comments URLThis field is for validation purposes and should be left unchanged.Share Your CommentsFirst Name*Last NameEmail* Shared Comments*This field is hidden when viewing the formI authorize the above comments be posted on this page Yes NoPost Comment I authorize the above comments be posted on this pageWeekly Digest Opt-In Yes, send me a weekly email with the latest lawsuits, recalls and warnings.Want your comments reviewed by a lawyer?To have an attorney review your comments and contact you about a potential case, provide your contact information below. This will not be published.Contact Phone #Alt Phone #Private CommentsNOTE: Providing information for review by an attorney does not form an attorney-client relationship.CAPTCHAGA SourceGA CampaignGA MediumGA ContentGA TermΔ MORE TOP STORIES Nearly 4,000 Bard PowerPort Lawsuits Are Awaiting Outcome of Upcoming Bellwether Trials (Posted: yesterday)C.R. Bard and its Becton Dickinson parent company face more than 3,700 Bard PowerPort lawsuits that claim the port catheters are defectively designed.MORE ABOUT: BARD POWERPORT LAWSUITBard PowerPort Lawyers Make Final Preparations for Next MDL Bellwether Trial (07/17/2026)New Trial Sought for First Bard PowerPort Bellwether Lawsuit (06/05/2026)Bard PowerPort Fracture Lawsuit Set For Second Bellwether Trial in Aug. 2026 (05/29/2026) Dupixent CTCL Studies Highlighted Cancer Risks For Years, Lawsuit Alleges (Posted: 2 days ago)A Dupixent CTCL lawsuit indicates manufacturers have long known the eczema treatment was linked to an increased cancer risk, but failed to warn doctors or patients.MORE ABOUT: DUPIXENT LAWSUITCTCL Lawsuit Alleges Diagnosis Came After Less Than a Year of Dupixent Use (07/29/2026)Lawsuit Alleges Dupixent Caused Mycosis Fungoides Diagnosis (07/21/2026)Dupixent MDL Judge To Meet With Lawyers for Initial Case Management Conference in October 2026 (06/25/2026) Abbott Continues to Oppose Spinal Cord Stimulator Lawsuit MDL, Despite Mounting Claims (Posted: 3 days ago)Manufacturer wants the Judicial Panel on Multidistrict Litigation to reject a proposal by a group of plaintiffs to consolidate all federal Abbott spinal cord stimulator lawsuits.MORE ABOUT: SPINAL CORD STIMULATOR LAWSUITLawsuit Over Spinal Cord Stimulator Removal Claims Device Caused Numbness, Incontinence (08/06/2026)Spine Stimulator Injury Lawyers Seek Leadership Roles in Boston Scientific MDL (07/31/2026)Spinal Cord Stimulator Reprogramming Caused Electric Shocks, Worsening Pain: Lawsuit (07/27/2026)
Nearly 4,000 Bard PowerPort Lawsuits Are Awaiting Outcome of Upcoming Bellwether Trials August 12, 2026
MDL Sought for Apple Lawsuits Over AirTag Stalking Problems and Damages Caused By Unauthorized Tracking August 12, 2026
Recalled LINX Device Caused Recurrence of GERD Symptoms, Requiring Surgical Removal: Lawsuit August 12, 2026
Nearly 4,000 Bard PowerPort Lawsuits Are Awaiting Outcome of Upcoming Bellwether Trials (Posted: yesterday)C.R. Bard and its Becton Dickinson parent company face more than 3,700 Bard PowerPort lawsuits that claim the port catheters are defectively designed.MORE ABOUT: BARD POWERPORT LAWSUITBard PowerPort Lawyers Make Final Preparations for Next MDL Bellwether Trial (07/17/2026)New Trial Sought for First Bard PowerPort Bellwether Lawsuit (06/05/2026)Bard PowerPort Fracture Lawsuit Set For Second Bellwether Trial in Aug. 2026 (05/29/2026)
Dupixent CTCL Studies Highlighted Cancer Risks For Years, Lawsuit Alleges (Posted: 2 days ago)A Dupixent CTCL lawsuit indicates manufacturers have long known the eczema treatment was linked to an increased cancer risk, but failed to warn doctors or patients.MORE ABOUT: DUPIXENT LAWSUITCTCL Lawsuit Alleges Diagnosis Came After Less Than a Year of Dupixent Use (07/29/2026)Lawsuit Alleges Dupixent Caused Mycosis Fungoides Diagnosis (07/21/2026)Dupixent MDL Judge To Meet With Lawyers for Initial Case Management Conference in October 2026 (06/25/2026)
Abbott Continues to Oppose Spinal Cord Stimulator Lawsuit MDL, Despite Mounting Claims (Posted: 3 days ago)Manufacturer wants the Judicial Panel on Multidistrict Litigation to reject a proposal by a group of plaintiffs to consolidate all federal Abbott spinal cord stimulator lawsuits.MORE ABOUT: SPINAL CORD STIMULATOR LAWSUITLawsuit Over Spinal Cord Stimulator Removal Claims Device Caused Numbness, Incontinence (08/06/2026)Spine Stimulator Injury Lawyers Seek Leadership Roles in Boston Scientific MDL (07/31/2026)Spinal Cord Stimulator Reprogramming Caused Electric Shocks, Worsening Pain: Lawsuit (07/27/2026)